logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

CareDx, Inc

CDNA

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cā€¦ read more

Healthcare

Diagnostics & Research

9 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$14.75

Price

-0.81%

-$0.12

$14.87

Previous Close

$14.88

Open

Premium

52w Discount
Market Cap

$785.097m

Small

Price/Earnings

14.1x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$340.826m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

$51.681m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

$1.02

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$327.370m

$444.257m

Assets

$116.887m

Liabilities

$29.122m

Debt
Debt to Assets

6.6%

-1x

Debt to EBITDA
Free Cash Flow

$17.847m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.